Interleukin-28B rs12979860 C allele: Protective against advanced fibrosis in chronic hepatitis C genotype 1 infection-Reference-Cited by-同舟云学术

Interleukin-28B rs12979860 C allele: Protective against advanced fibrosis in chronic hepatitis C genotype 1 infection

Published:2014-07 Issue:7 Volume:29 Page:1458-1462
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:J Gastroenterol Hepatol

Author:

Kitson Matthew T¹²,George Jacob³,Dore Gregory J⁴,Leung Reynold³,Button Peter⁵,McCaughan Geoffrey W⁶,Crawford Darrell H G⁷,Sievert William²⁸,Weltman Martin D⁹,Cheng Wendy S C¹⁰,Roberts Stuart K¹²,

Affiliation:

1. Department of Gastroenterology; Alfred Hospital; Melbourne Victoria Australia

2. Department of Gastroenterology; Monash University; Melbourne Victoria Australia

3. Storr Liver Unit; Westmead Millenium Institute; University of Sydney and Westmead Hospital; Sydney New South Wales Australia

4. Kirby Institute; University of New South Wales; Sydney New South Wales Australia

5. Infopeople Pty. Ltd; Sydney New South Wales Australia

6. AW Morrow Gastroenterology & Liver Centre; Royal Prince Alfred Hospital and Centenary Research Institute; Sydney New South Wales Australia

7. Department of Medicine; University of Queensland; Brisbane Queensland Australia

8. Department of Gastroenterology; Monash Medical Centre; Melbourne Victoria Australia

9. Department of Medicine; Nepean Hospital; Sydney New South Wales Australia

10. Liver Unit; Royal Perth Hospital; Perth Western Australia Australia

Funder

Medical Postgraduate Research Scholarship from the National Health and Medical Research Council (NHMRC) of Australia

NHMRC Practitioner Fellowship

Robert W. Storr Bequest to the University of Sydney

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jgh.12544/fullpdf

Reference21 articles.

1. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance;Ge;Nature,2009

2. IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy;Suppiah;Nat. Genet.,2009

3. Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C;Tanaka;Nat. Genet.,2009

4. Does IL28B genotyping still have a role in the era of direct-acting antiviral therapy for chronic hepatitis C infection?;Holmes;J. Viral Hepat.,2012

5. Common variation of IL28 affects gamma-GTP levels and inflammation of the liver in chronically infected hepatitis C virus patients;Abe;J. Hepatol.,2010

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IL28B rs12979860 and rs8099917 polymorphisms in patients with chronic hepatitis C and non-viral liver disease;Annals of Clinical and Analytical Medicine;2022

2. Extracellular Matrix Proteins Substantiate IL-28B T allele Effect on Histological Outcome of Chronic Hepatitis C;Annals of Hepatology;2018-07

3. Hepatic IFNL4 expression is associated with non-response to interferon-based therapy through the regulation of basal interferon-stimulated gene expression in chronic hepatitis C patients;Journal of Medical Virology;2017-02-27

4. Chronic hepatitis C infection and liver disease in HIV-coinfected patients in Asia;Journal of Viral Hepatitis;2016-12-05

5. Association with Spontaneous Hepatitis C Viral Clearance and Genetic Differentiation of IL28B/IFNL4 Haplotypes in Populations from Mexico;PLOS ONE;2016-01-07